It is a link to move in the page.
To global navigation
To the text
To local navigation
To site information
Font Size
Language
news release
April 25, 2013
Teijin launches WalkAide® device in Japan to help stroke survivors and others with partial paralysis resume walking
January 17, 2013
Teijin Pharma to launch Ipsen’s Somatuline® subcutaneous injection in the treatment of acromegaly and pituitary gigantism in Japan
Archives
corporate profile
Message from the President
Corporate Profile
Overview of Core Business
Global Operations
Compliance
Organization
Corporate Social Responsibility(CSR)
Synergies of the Teijin Group
Research and Development
Customer and marketing support services
History
Office Locations
